-
1 Comment
Korian is currently in a long term uptrend where the price is trading 5.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
Korian's total revenue sank by 0.0% to $923M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $32M since the same quarter in the previous year.
Finally, its free cash flow grew by 98.6% to $237M since the same quarter in the previous year.
Based on the above factors, Korian gets an overall score of 3/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | FR0010386334 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | 1B |
|---|---|
| PE Ratio | None |
| Dividend Yield | None |
| Beta | 0.9 |
Clariane SE provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. The company operates long-term care and short stays nursing homes. It also provides diagnosis outpatient programs; healthcare services comprising medical and full hospitalization services, as well as day hospitalisation and consultations; and operates post-acute and rehabilitation care facilities, mental healthcare clinics, hospital home care networks, and home community nursing facilities. In addition, the company offers home care and hospital home care services; and assisted living residences or shared housing. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KO2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
